{
    "title": "Extended-release drugs could be costing U.S. healthcare system billions",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8056847/Extended-release-drugs-costing-U-S-healthcare-billions.html",
    "date": "2020-02-28",
    "keywords": [
        "extendedrelease",
        "version",
        "day",
        "medicare",
        "pandey",
        "form",
        "difference",
        "medication",
        "drug",
        "part",
        "price",
        "gellad",
        "health",
        "healthcare",
        "study",
        "spending",
        "jama",
        "network",
        "cost",
        "dr",
        "university",
        "center",
        "set",
        "database",
        "insurance",
        "program",
        "problem",
        "carroll",
        "system",
        "convenience",
        "coauthor",
        "texas",
        "schedule",
        "team",
        "prescription",
        "medicaid",
        "utilization",
        "state",
        "federalstate",
        "list",
        "brandname",
        "generic",
        "year",
        "total",
        "period",
        "switch",
        "way",
        "point",
        "foot",
        "immediaterelease",
        "paper",
        "concept",
        "decrease",
        "company",
        "director",
        "pittsburgh",
        "policy",
        "doesnt",
        "example",
        "metformin",
        "lot",
        "upset",
        "shortacting",
        "wouldnt",
        "source",
        "httpbitly39bvq5s",
        "online"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}